Back to Rankings

XERS

Xeris BiopharmaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
XERS vs peer average
68/100
XERS vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CDNA is the first available peer comparator.

Primarily a size peer rather than an operating comp; diagnostics reimbursement and testing-utilization dynamics differ meaningfully from Xeris' branded-product commercial model.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCDNACareDx
XERS
Xeris Biopharma
CDNA
CareDx
Grade
B
B
Momentum
36
78
Value
59
50
Sentiment
81
56
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs CDNA

XERS / CDNA
Grade Position
In line
XERS vs. peer average (B vs. C)
68/100
Momentum
36
CDNA
Value
59
XERS
Sentiment
81
XERS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XERS
1
CDNA
CDNA
B
80/100
Even
2
MNKD
MNKD
A
100/100
-1
3
ALVO
ALVO
F
20/100
+3
4
AKTS
Aktis Oncology Inc Common
N/A
-
-
5
DBVT
DBV Technologies SA ADR
B
80/100
Even
CDNA is the first peer returned for this comparison set.